Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Data exclusivity for biologics

An Erratum to this article was published on 01 June 2011

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Cumulative net present value (NPV) of cash flows for a representative biologic with various scenarios for market exclusivity.
Figure 2: Influence of data exclusivity and patent protection on break-even points for a representative biologic portfolio.

References

  1. Title VII of the Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111–48, Improving Access to Innovative Medical Therapies—Subtitle (2010).

  2. Grabowski, H. Follow-on biologics: data exclusivity and the balance between innovation and competition. Nature Rev. Drug Discov. 7, 479–488 (2008).

    CAS  Article  Google Scholar 

  3. Federal Trade Commission (FTC). Emerging Health Care Issues: Follow-on Biologic Drug Competition. Federal Trade Commission Report | June 2009. FTC website [online], (2009).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henry Grabowski.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information Box S1

Details of modelling and analysis (PDF 356 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Grabowski, H., Long, G. & Mortimer, R. Data exclusivity for biologics. Nat Rev Drug Discov 10, 15–16 (2011). https://doi.org/10.1038/nrd3277

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3277

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing